NALTREXONE IN PRIMARY HYPERPHAGIC OBESITY WITY HYPOCHONDRIACAL DISORDER - A CLINICAL STUDY

Six well investigated patients of primary hyperphagic obesity with hypochondrical disorder were sequentially treated with psychoeducational methods alone and psychoeducational methods with naltrexone hydrochloride 50 mg daily orally for six weeks each. RMANOVA revealed no statically significant (p&g...

Descripción completa

Detalles Bibliográficos
Autores principales: Pandey, Ravi S., Arya, S.C., Subbakrishna, D.K.
Formato: Texto
Lenguaje:English
Publicado: Medknow Publications 1999
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2962832/
https://www.ncbi.nlm.nih.gov/pubmed/21455371
_version_ 1782189216185188352
author Pandey, Ravi S.
Arya, S.C.
Subbakrishna, D.K.
author_facet Pandey, Ravi S.
Arya, S.C.
Subbakrishna, D.K.
author_sort Pandey, Ravi S.
collection PubMed
description Six well investigated patients of primary hyperphagic obesity with hypochondrical disorder were sequentially treated with psychoeducational methods alone and psychoeducational methods with naltrexone hydrochloride 50 mg daily orally for six weeks each. RMANOVA revealed no statically significant (p>0.05) decrease in body mass index suggesting that psychoeducational methods with naltrexone were as ineffective in reducing obesity as psychoeducational methods alone. The limitations of the study and implications for future research are discussed.
format Text
id pubmed-2962832
institution National Center for Biotechnology Information
language English
publishDate 1999
publisher Medknow Publications
record_format MEDLINE/PubMed
spelling pubmed-29628322011-03-31 NALTREXONE IN PRIMARY HYPERPHAGIC OBESITY WITY HYPOCHONDRIACAL DISORDER - A CLINICAL STUDY Pandey, Ravi S. Arya, S.C. Subbakrishna, D.K. Indian J Psychiatry Original Article Six well investigated patients of primary hyperphagic obesity with hypochondrical disorder were sequentially treated with psychoeducational methods alone and psychoeducational methods with naltrexone hydrochloride 50 mg daily orally for six weeks each. RMANOVA revealed no statically significant (p>0.05) decrease in body mass index suggesting that psychoeducational methods with naltrexone were as ineffective in reducing obesity as psychoeducational methods alone. The limitations of the study and implications for future research are discussed. Medknow Publications 1999 /pmc/articles/PMC2962832/ /pubmed/21455371 Text en Copyright: © Indian Journal of Psychiatry http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Pandey, Ravi S.
Arya, S.C.
Subbakrishna, D.K.
NALTREXONE IN PRIMARY HYPERPHAGIC OBESITY WITY HYPOCHONDRIACAL DISORDER - A CLINICAL STUDY
title NALTREXONE IN PRIMARY HYPERPHAGIC OBESITY WITY HYPOCHONDRIACAL DISORDER - A CLINICAL STUDY
title_full NALTREXONE IN PRIMARY HYPERPHAGIC OBESITY WITY HYPOCHONDRIACAL DISORDER - A CLINICAL STUDY
title_fullStr NALTREXONE IN PRIMARY HYPERPHAGIC OBESITY WITY HYPOCHONDRIACAL DISORDER - A CLINICAL STUDY
title_full_unstemmed NALTREXONE IN PRIMARY HYPERPHAGIC OBESITY WITY HYPOCHONDRIACAL DISORDER - A CLINICAL STUDY
title_short NALTREXONE IN PRIMARY HYPERPHAGIC OBESITY WITY HYPOCHONDRIACAL DISORDER - A CLINICAL STUDY
title_sort naltrexone in primary hyperphagic obesity wity hypochondriacal disorder - a clinical study
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2962832/
https://www.ncbi.nlm.nih.gov/pubmed/21455371
work_keys_str_mv AT pandeyravis naltrexoneinprimaryhyperphagicobesitywityhypochondriacaldisorderaclinicalstudy
AT aryasc naltrexoneinprimaryhyperphagicobesitywityhypochondriacaldisorderaclinicalstudy
AT subbakrishnadk naltrexoneinprimaryhyperphagicobesitywityhypochondriacaldisorderaclinicalstudy

Ejemplares similares